Risk factors for anaphylaxis in patients with mastocytosis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 125, Issue 1-2, 2015, Pages 46-53

  Górska, Aleksandra ^a   Niedoszytko, Marek ^a   Lange, Magdalena ^a   Chełmiñska, Marta ^a   Nedoszytko, Bogusław ^a   Wasąg, Bartosz ^a   Słomiñski, Jan Marek ^a   Gruchała Niedoszytko, Marta ^a   Nowicki, Roman ^a   Jassem, Ewa ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Anaphylaxis; Effectiveness of treatment; Mastocytosis; Mediators; Risk factors

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BEE VENOM; CONTRAST MEDIUM; CORTICOSTEROID; FOOD ALLERGEN; HISTAMINE; IMMUNOGLOBULIN E; INSECT VENOM; LOCAL ANESTHETIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; TRYPTASE; ALLERGEN;

ADULT; AGED; ALLERGIC REACTION; ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; EGG; ENZYME BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; FOOD ALLERGY; HAZELNUT; HISTOPATHOLOGY; HUMAN; HYMENOPTERA; HYPOTENSION; IMMUNOTHERAPY; INCIDENCE; INSECT STING; MAJOR CLINICAL STUDY; MALE; MAST CELL; MASTOCYTOSIS; MEAT; MILK; MUTATION; NUTRITIONAL INTOLERANCE; PREVALENCE; PRICK TEST; PROPHYLAXIS; PROSPECTIVE STUDY; REMISSION; RISK FACTOR; SPICE; SYSTEMIC MASTOCYTOSIS; TOMATO; TREATMENT RESPONSE; ADOLESCENT; BLOOD; COMPARATIVE STUDY; COMPLICATION; INSECT BITE; MIDDLE AGED; POLAND; SEX DIFFERENCE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLERGENS; ANAPHYLAXIS; FEMALE; HUMANS; INCIDENCE; INSECT BITES AND STINGS; MALE; MASTOCYTOSIS; MIDDLE AGED; POLAND; PREVALENCE; RISK FACTORS; SEX FACTORS; TRYPTASES; YOUNG ADULT;

EID: 84924301944     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2644     Document Type: Article

References (30)

1. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria. Eur J Clin Invest. 2007; 37: 435-453.
2. Bonadonna P, Perbellini O, Passalacqua G, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009; 3: 680-686.
3. Akin C. Anaphylaxis and Mast Cell Disease: What Is the Risk? Curr Allergy Asthma Rep. 2010; 10: 34-38.
4. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idio-pathic" anaphylaxis. Blood. 2007; 110: 2331-2333.
5. Ruëff F, Wenderoth A, Przybilla B. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses. J Allergy Clin Immunol. 2001; 108: 1027-1032.
6. Brockow K, Jofer C, Behrendt H, et al. Anaphylaxis in patients with mas-tocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008; 63: 226-232.
7. Brockow K, Jofer C, Ring J. Anaphylaxis in patients with mastocytosis: a prospective study on prevalence, severity and trigger factors in 121 patients [abstract]. J Allergy Clin Immunol. 2006; 117: S307.
8. Ludolph-Hauser D, Ruëff F, Fries C, et al. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hy-menoptera stings. Lancet. 2001; 357: 361-362.
9. Haeberli G, Bronnimann M, Hunziker T, et al. Elevated basal serum trypt-ase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003; 33: 1216-1220.
10. Müller UR, Horat W, Wüthrich B, et al. Anaphylaxis after hymenoptera stings in three patients with urticaria pigmentosa. J Allergy Clin Immunol. 1983; 72: 685-689.
11. Peavy R, Metcalfe D. Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol. 2008; 8: 310-315.
12. Helbig G, Kyrcz-Krzemien S. Diagnostic and therapeutic management in patients with hypereosinophilic syndromes. Pol Arch Med Wewn. 2011; 121: 44-52.
13. Akin C, Valent P, Metcalfe D. Mast cell activation syndrome: Proposed diagnostic criteria. J Allergy Clin Immunol. 2010; 126: 1099-1104.
14. Heide R, van Doorn K, Mulder PG, et al. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneus mastocytosis. Clin Exp Dermatol. 2009; 34: 462-468.
15. Johansson SG, Hourihane JO, Bousquet J, et al. EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy. 2001; 56: 813-24.
16. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the world Allergy Organization, October 2003. J Allergy Clin Immunol. 2004; 113: 832-836.
17. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977; 1: 466-469.
18. Pawliczak R. New horizons in allergy diagnostics and treatment. Pol Arch Med Wewn. 2013; 123: 246-250.
19. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010; 125: 161-181.
20. Niedoszytko M, de Monchy J, van Doormaal J, et al. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunother-apy. Allergy. 2009; 64: 1237-1245.
21. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol. 2006; 97: 39-43.
22. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005; 60: 443-451.
23. Vlieg-Boerstra BJ, van der Heide S, Oude Elbering JNG, et al. Masto-cytosis and adverse reactions to biogenic amines and histamine-releasing foods: what is the evidence? Neth J Med. 2005; 63: 244-249.
24. Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol. 2007; 7: 387-392.
25. Ruëff F, Placzek M, Przybilla B. Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol. 2006; 6: 284-288.
26. van Anrooij B, van der Veer E, de Monchy JG, et al. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol. 2013; 132: 125-130.
27. Valent P, Sperr WR, Schwartz LB, et al. Classification of systemic mast cell disorders: Delineation from immunologic disease and non mast cell lineage hematopoetic neoplasms. J Allergy Clin Immunol. 2004; 114: 3-11.
28. Brockow K, Ring J. Update on diagnosis and treatment of mastocyto-sis. Curr Allergy Asthma Rep. 2011; 11: 292-299.
29. Clark S, Long AA, Gaeta TJ, et al. Multicenter study of emergency department visits for insect sting allergies. J Allergy Clin Immunol. 2005; 116: 643-649.
30. Clark S, Bock SA, Gaeta TJ, et al. Multicenter study of emergency department visits for food allergies. J Allergy Clin Immunol. 2004; 113: 347-352.